Is Seagen (SGEN) making Money?
However, Seagen (NASDAQ: SGEN) is not making money from its cancer drugs. For instance, Seagen reported a quarterly operating loss of -$93.97 million on 30 June 2020.
Read moreHowever, Seagen (NASDAQ: SGEN) is not making money from its cancer drugs. For instance, Seagen reported a quarterly operating loss of -$93.97 million on 30 June 2020.
Read more